Old Before Rich: Vietnam's Healthcare Demand Is Certain. Its Ability to Pay Is Not.

Insights from Vietnam 1T SUMMIT — Jan 7th, 2026
— Vietnam Vanguard

Vietnam will become an aged society around 2036, roughly a decade before it intends to become a high-income one. That ten-year gap is the most important number in the private healthcare investment case, and the one least discussed.

Private healthcare in Vietnam is sold to investors as the closest thing to a demographic certainty: an aging population, rising chronic disease, a public system under strain, and 100 million people who will need more care than the state can provide. Every part of that is true. It is also incomplete in a way that matters, because demand for healthcare and the capacity to pay for it are different variables, and Vietnam's are diverging on a timeline the sector's own investment case tends to elide.

Dr. Melvin Heng, Group CEO of Thomson Medical, speaking at 1T SUMMIT Jan 7th 2026 in Ho Chi Minh City, Vietnam

The Demand Side Is Not in Question

Melvin Heng, Group CEO of Thomson Medical — which acquired FV Hospital, one of Vietnam's oldest private hospitals, in 2023 — describes hospitals as infrastructure assets that happen to carry unusually complex software and hardware. His read on why Vietnam works as a market is straightforwardly demographic: the country is moving toward more than 10% of its population above 65 within roughly half a decade, bringing significant drawdowns in cardiology, oncology and orthopaedics, and with them demand for technology transfer, better diagnostics, more capable specialists, and better implants.

The published data supports him and, if anything, understates the pace. Vietnamese aged 65 and over already comprise about 9.3% of the population. The country crossed into "ageing society" status in 2015 and is projected to reach "aged society" — the 14% threshold — around 2035 or 2036. What distinguishes Vietnam is not the destination but the speed: France and Sweden took 85 to 115 years to make that same transition. Vietnam will do it in roughly 25. The ASEAN+3 Macroeconomic Research Office puts Vietnam's ageing-to-aged transition at 18 years, faster than Thailand, Indonesia, Malaysia, the Philippines, or Japan.

Heng's second observation is about sophistication rather than volume, and it is the more commercially consequential one. Vietnamese patients increasingly expect that a technology available in the United States should be available here, and they expect service standards to match. He recounts pressing a regulator on delays importing surgical robotics with a question that reframed the issue: whether the country was prepared to accept a lesser standard of care because of procurement friction. It is a fair question, and it points at a real cost structure. Meeting those expectations requires imported equipment, expatriate-standard clinical talent, and continuous technology refresh — a capital-intensive model priced in hard currency.

Main lobby, FV Hospital in Phu My Hung, Tan My Ward, Ho Chi Minh City, Vietnam

The Payment Side Is Where the Case Thins

Here is the gap the demographic argument tends to skip. Vietnam is on track to become an aged society around 2036. It has separately set 2045 as its target for high-income status. Vietnam's own Ministry of Health officials have named the resulting problem directly: the country is likely to grow old before it grows rich, entering the aged phase almost a decade before the wealth threshold it is aiming for.

The financing infrastructure reflects that gap. As of end-2022, only 38% of Vietnam's working-age population participated in the social insurance pension scheme — well short of the 60% coverage target set for 2030. Life expectancy has risen impressively, from 65.5 years in 1993 to 74.7 in 2024, but Vietnamese spend an average of roughly 14 years of that lifespan in poor health. That combination — long-duration morbidity, thin pension coverage, and an aged population arriving before high-income status — describes a large population with acute clinical need and constrained private purchasing power.

Private healthcare does not serve that whole population, and its investment case does not depend on doing so. But it does depend on the size and durability of the segment that can pay, and that segment's growth is tied to income growth arriving fast enough to outrun the ageing curve. That is a genuinely contested assumption, not a demographic given.

The Elasticity Nobody Prices

Heng supplied the most useful piece of evidence against his own sector's defensiveness, and it is worth taking seriously precisely because it came from an operator rather than a critic. When tariffs were announced on what the US administration termed Liberation Day, his hospital received cancellations of surgeries — because uncertainty was in the air. As he put it, people are practical: they will want to put bread on the table before they engage with their health.

That single observation complicates the standard framing of healthcare as a defensive, recession-resistant asset class. In a market where a substantial share of private healthcare is paid out of pocket rather than through insurance, elective and semi-elective procedures behave like discretionary consumption. They get deferred when households feel uncertain — and they were deferred, in Vietnam, in response to a trade policy announcement made in another country. Healthcare demand in aggregate is demographically locked in. Private healthcare revenue, in the near term, is not, and it is correlated with exactly the export-manufacturing exposure that drives the rest of Vietnam's economy.

Heng's own answer to what would make the sector more investable is notably not about demand at all. He points to public policy architecture: whether Vietnam moves toward a single-payer, multi-payer, or market-driven model; how much of the population the state intends to cover; how far social insurance is designed to stretch; and the practical infrastructure, such as digital identity enabling portable health records, that removes friction from the system. That is an accurate diagnosis. It also means the private healthcare investment case rests on policy decisions that have not been made yet, rather than on demographics that have.

What This Means for the Room

For healthcare investors and operators: underwrite the payment mechanism, not the population pyramid. The relevant variables are social insurance coverage expansion against its 60%-by-2030 target, private health insurance penetration, and the growth rate of the household segment able to pay out of pocket — not the 65-plus share, which is already effectively certain and already priced.

For policymakers: the sequencing question is sharper than the spending question. Vietnam has roughly a decade between reaching aged-society status and reaching its high-income target, and the financing architecture built during that window — payer model, insurance coverage depth, portability of health records — determines whether private capital funds capacity expansion or waits for clarity. Heng's point about friction is the actionable one: procurement and regulatory delay on medical technology raises the cost of every private facility and is comparatively cheap to fix.

For corporate leaders outside the sector: the ageing curve arrives inside the working lives of your current workforce. A 25-year transition to aged society means the employers absorbing the healthcare cost of an older workforce are the same ones now competing for young talent, and employer-provided health coverage is likely to shift from a differentiator to a baseline expectation faster than most workforce plans assume.

The demographic case for Vietnamese healthcare is the easiest investment argument in the market to make and the least informative. Everyone can see the population pyramid. What separates a good position in this sector from a bad one is a judgment about whether Vietnam builds the financing architecture before or after the ageing curve arrives — and on current evidence, the curve is moving faster than the architecture.

Insights from Vietnam 1T SUMMIT — Jan 7th, 2026
— Vietnam Vanguard